Wednesday, September 04, 2019 10:15:29 AM
My wife is a Renal PA . Most of her patients are on dialysis .
All of her patients hate the current standard of care for trying to maintain serum phosphorus levels below 5.5 mg/dl
...multiple tablets with every meal .
Non compliance is a huge problem .
So the results from the current study are really important for dialysis patients as it offers the possibility that they can dial back the number of phosphate binders they are currently required to take ....replacing these tablets with 2 small twice a day pills.
Some background /comments
There are around 700,000 dialysis patients in the US,EU,Japan combined .
85% of them need phosphate binders to try and get their serum phosphorus levels around 5.5 mg/dl
In the current study only 3 of the 116 patients in the active arm ( Tenapanor and binders ) discontinued the trial due to loose stool / diarrhea .
Most dialysis patients complain of constipation and may only have 2-3 bowel movements per week. While adding Tenapanor may increase the number of bowel movements to 5-6 times a week ...this will be seen by mostly as a good thing for these patients as it represents normal life pre dialysis.
The concern about loose stool etc in these patients is IMHO largely exaggerated.
Company has a market cap today of around $330m and reminds me a lot of the companies like ZS Pharma and RLYP that developed hyperkalemia drugs for the dialysis population .
Both were eventually brought out by BP at far higher prices .
Risks near term
Company will need financing ...either before or after their final P 3 ...results in Q4
Monotherapy trial ...the final P 3... may have bigger issues with loose stool etc .
The current binders patients are on create constipation ...when Tenapanor is added the loose stool side effect offsets this constipation creating a sense of more normal bowel movements .
In Monotherapy ( only Tenapanor ) there will be no "constipation offset " ...so loose stool / diarrhea may be a bigger issue .
JMO ...I'm adding or any significant sell offs
Kiwi
Recent ARDX News
- The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ARDX • PR Newswire (US) • 09/19/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 10:14:31 PM
- Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact The Gross Law Firm about pending Class Action - ARDX • PR Newswire (US) • 09/16/2024 09:45:00 AM
- Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDX • PR Newswire (US) • 09/12/2024 09:45:00 AM
- Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 09/09/2024 09:45:00 AM
- Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline • PR Newswire (US) • 09/05/2024 09:45:00 AM
- Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDX • PR Newswire (US) • 08/29/2024 09:45:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/26/2024 08:49:14 PM
- Class Action Filed Against Ardelyx, Inc. (ARDX) - October 15, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 08/26/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:28:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:26:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:25:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:21:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 10:20:33 PM
- Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 08/22/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 10:59:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:10:41 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2024 10:08:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 08:28:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:04:44 PM
- Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer • GlobeNewswire Inc. • 08/08/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:03:32 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM